Trial intelligence / Profile preview

Measurement of Urethral Function in Women with Stress Urinary Incontinence using [S,S]-Reboxetine

2004-001559-12Phase 2Completed

Sponsor
Pfizer
Start
Jul 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of reboxetine in stress urinary incontinence (SUI), sponsored by Pfizer. Primary endpoint: Opening urethral pressure (Reflectometry). Started Jul 2005; status: completed.

02

Drugs

reboxetine
03

Conditions

stress urinary incontinence (SUI)

Beyond the preview

Go deeper on 2004-001559-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-001559-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call